| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |